Opposite nociceptive effects of the arginine/NO/cGMP pathway stimulation in dermal and subcutaneous tissues
- 1 April 2003
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 138 (7) , 1351-1357
- https://doi.org/10.1038/sj.bjp.0705181
Abstract
1. Nitric oxide has been described either as pronociceptive or antinociceptive. In this investigation, using an electronic pressure-metre, the intradermal and the subcutaneous effects of prostaglandin E(2) (PGE(2)) and agents that mimic or inhibit the arginine/NO/cGMP pathway were compared. 2. The hypernociceptive effect of the intradermal injection of PGE(2) (100 ng) was immediate, peaking within 15-30 min and returning to basal values in 45-60 min. The subcutaneous injection of PGE(2) induced a hypernociception with a delayed peak (3 h) plateauing for 4-6 h. 3. Intradermal administration of 3-morpholino-sydnonimine-hydrochloride (SIN-1) enhanced, while its subcutaneous administration inhibited, subcutaneous hypernociception induced by PGE(2). This inhibition was prevented by ODQ (8 micro g) but not by NG-monomethyl-L-arginine (L-NMMA) (50 micro g). 4. Intradermal but not subcutaneous administration of L-arginine (1-100 micro g), SIN-1 (1-100 micro g) and dibutyrylguanosine 3':5'-cyclic monophosphate (db cGMP) (0.1-100 micro g) induced an early (15-30 min) dose-dependent hypernociceptive effect. Intradermal pretreatment with NG-monomethyl-L-arginine (L-NMMA; 50 micro g) inhibited the hypernociception induced by L-Arg (10 micro g), but not that induced by SIN-1 (10 micro g) or db cGMP (10 micro g). 5. Intradermal injection of ODQ (8 micro g) antagonized the hypernociception induced by L-arginine and SIN-1, but not that induced by db cGMP. 6. Considering (a) the different time course of intradermal and subcutaneous PGE(2)-induced hypernociception, (b) the opposite nociceptive effect of intradermal and subcutaneous administration of SIN-1 (db cGMP) as well as the arginine/NO/cGMP pathway, the existence of different subsets of nociceptive primary sensory neurons in which the arginine/NO/cGMP pathway plays opposing roles is suggested. This hypothesis would explain the apparent contradictory observations described in the literature.Keywords
This publication has 43 references indexed in Scilit:
- NO‐naproxen modulates inflammation, nociception and downregulates T cell response in rat Freund's adjuvant arthritisBritish Journal of Pharmacology, 2000
- The peripheral antinociceptive effect induced by morphine is associated with ATP‐sensitive K+ channelsBritish Journal of Pharmacology, 2000
- The cAMP transduction cascade mediates the PGE2‐induced inhibition of potassium currents in rat sensory neuronesThe Journal of Physiology, 1999
- Nitric oxide evokes pain in humans on intracutaneous injectionNeuroscience Letters, 1994
- Comparison of intradermal and subcutaneous hyperalgesic effects of inflammatory mediators in the ratNeuroscience Letters, 1993
- An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the ratPain, 1992
- The changing role of primary afferent neurones in painPain, 1990
- Novel classes of nociceptors: beyond SherringtonTrends in Neurosciences, 1990
- A novel type of unmyelinated chemosensitive nociceptor in the acutely inflamed urinary bladderInflammation Research, 1988
- The hyperalgesic effects of prostacyclin and prostaglandin E2Prostaglandins, 1978